TY - JOUR
T1 - Intraoperative Use of a Portable Large Field of View Gamma Camera and Handheld Gamma Detection Probe for Radioguided Localization and Prediction of Complete Surgical Resection of Gastrinoma
T2 - Proof of Concept
AU - Hall, Nathan C.
AU - Nichols, Shawnn D.
AU - Povoski, Stephen P.
AU - James, Iyore A.O.
AU - Wright, Chadwick L.
AU - Harris, Randall
AU - Schmidt, Carl R.
AU - Muscarella, Peter
AU - Latchana, Nicholas
AU - Martin, Edward W.
AU - Ellison, E. Christopher
N1 - Publisher Copyright:
© 2015 American College of Surgeons.
PY - 2015/8/1
Y1 - 2015/8/1
N2 - Background Surgical management of Zollinger-Ellison syndrome (ZES) relies on localization and resection of all tumor foci. We describe the benefit of combined intraoperative use of a portable large field of view gamma camera (LFOVGC) and a handheld gamma detection probe (HGDP) for indium-111 (111In)-pentetreotide radioguided localization and confirmation of gastrinoma resection in ZES. Study Design Five patients (6 cases) with 111In-pentetreotide-avid ZES were evaluated. Patients were injected with 111In-pentetreotide for diagnostic imaging the day before surgery. Intraoperatively, an HGDP and LFOVGC were used to localize 111In-pentetreotide-avid lesions, guide resection, assess specimens for 111In-pentetreotide activity, and to verify lack of abnormal post-resection surgical field activity. Results Large field of view gamma camera imaging and HGDP-assisted detection were helpful for localization and guided resection of tumor and removal of 111In-pentetreotide-avid tumor foci in all cases. In 3 of 5 patients (3 of 6 cases), these techniques led to detection and resection of additional tumor foci beyond those detected by standard surgical techniques. The 111In-pentetreotide-positive or-negative specimens correlated with neuroendocrine tumors or benign pathology, respectively. In one patient with mild residual focal activity on post-resection portable LFOVGC imaging, thought to be artifact, had recurrence of disease in the same area 5 months after surgery. Conclusions Real-time LFOVGC imaging and HGDP use for surgical management of gastrinoma improve success of localizing and resecting all neuroendocrine tumor-positive tumor foci, providing instantaneous navigational feedback. This approach holds potential for improving long-term patient outcomes in patients with ZES.
AB - Background Surgical management of Zollinger-Ellison syndrome (ZES) relies on localization and resection of all tumor foci. We describe the benefit of combined intraoperative use of a portable large field of view gamma camera (LFOVGC) and a handheld gamma detection probe (HGDP) for indium-111 (111In)-pentetreotide radioguided localization and confirmation of gastrinoma resection in ZES. Study Design Five patients (6 cases) with 111In-pentetreotide-avid ZES were evaluated. Patients were injected with 111In-pentetreotide for diagnostic imaging the day before surgery. Intraoperatively, an HGDP and LFOVGC were used to localize 111In-pentetreotide-avid lesions, guide resection, assess specimens for 111In-pentetreotide activity, and to verify lack of abnormal post-resection surgical field activity. Results Large field of view gamma camera imaging and HGDP-assisted detection were helpful for localization and guided resection of tumor and removal of 111In-pentetreotide-avid tumor foci in all cases. In 3 of 5 patients (3 of 6 cases), these techniques led to detection and resection of additional tumor foci beyond those detected by standard surgical techniques. The 111In-pentetreotide-positive or-negative specimens correlated with neuroendocrine tumors or benign pathology, respectively. In one patient with mild residual focal activity on post-resection portable LFOVGC imaging, thought to be artifact, had recurrence of disease in the same area 5 months after surgery. Conclusions Real-time LFOVGC imaging and HGDP use for surgical management of gastrinoma improve success of localizing and resecting all neuroendocrine tumor-positive tumor foci, providing instantaneous navigational feedback. This approach holds potential for improving long-term patient outcomes in patients with ZES.
UR - http://www.scopus.com/inward/record.url?scp=84937707147&partnerID=8YFLogxK
U2 - 10.1016/j.jamcollsurg.2015.03.047
DO - 10.1016/j.jamcollsurg.2015.03.047
M3 - Article
C2 - 26206636
AN - SCOPUS:84937707147
SN - 1072-7515
VL - 221
SP - 300
EP - 308
JO - Journal of the American College of Surgeons
JF - Journal of the American College of Surgeons
IS - 2
ER -